ChinaBulls

HuiCore Bio汇芯生物

Biotech/Healthcare

Huixin Biotech focuses on technological innovation in exosome purification and exosome-based early cancer diagnosis. Working with multiple research institutions and drawing on its team’s extensive medical device experience, the company has developed a new automated, label-free exosome isolation and…

Source: ChinaBulls — chinabulls.com

Last updated 2026-02-01

Funding Rounds

  • Series A Extension
    RaisedFunding amount requires an account.

    Create Account to Unlock Full Data for Free

    SIGN UP

HuiCore Bio Fundraising Info

Company fundraising information requires an account.

HuiCore Bio Investors and Backers

Unlock Full Data for Free

Get access to market data, insights, backers, analytics and funding rounds.

SIGN UP